The present study had two main goals: (1) to investigate whether CRP is associated with brain structural alterations in the context of AD [patients with subjective cognitive decline (SCD), patients with MCI and patients with AD], and (2), whether CRP is associated with cognitive changes among patients with different stages of cognitive impairments. This evidence concerns the gene CRP and Cognitive impairment.